Outlook Therapeutics Inc
NASDAQ:OTLK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Outlook Therapeutics Inc
NASDAQ:OTLK
|
US |
|
Royal Bafokeng Platinum Ltd
F:7BF
|
ZA |
|
NRJ Group SA
F:NR8
|
FR |
Intrinsic Value
The intrinsic value for
Outlook Therapeutics Inc (OTLK) under the Base Case is 0.5218 USD.
Compared with the current market price of 0.8782 USD, the stock appears
Overvalued by 41% .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Outlook Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Outlook Therapeutics Inc
Earnings Waterfall
Outlook Therapeutics Inc
The intrinsic value for
Outlook Therapeutics Inc (OTLK) under the Base Case is 0.5218 USD.
Compared with the current market price of 0.8782 USD, the stock appears Overvalued by 41% .